WallStreetZenWallStreetZen

NASDAQ: DSGN
Design Therapeutics Inc Stock Ownership - Who owns Design Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Design Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Arsani WilliamDirector2024-08-09814,874$4.25
$3.46MSell
Heather A. BergerDirector2024-03-251,300$3.74
$4.87kBuy
John P. SchmidDirector2024-03-2517,809$3.74
$66.61kBuy
John P. SchmidDirector2024-03-229,156$3.62
$33.14kBuy
Rodney W. LappeDirector2023-09-2921,000$2.35
$49.29kBuy

1 of 1

DSGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DSGN insiders and whales buy or sell their stock.

DSGN Shareholders

What type of owners hold Design Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Simeon George21.46%12,152,952$57.24MInsider
Sr One Capital Fund I Aggregator LP11.53%6,526,476$30.74MInsider
Sr One Capital Management LP11.53%6,526,476$30.74MInstitution
Cormorant Asset Management LP9.03%5,114,844$24.09MInsider
Arsani William8.89%5,032,501$23.70MInsider
Logos Global Management LP8.89%5,032,501$23.70MInstitution
Quan Venture Fund Ii LP8.34%4,720,830$22.24MInsider
Stella Xu7.31%4,139,950$19.50MInsider
Blackrock Inc4.07%2,304,948$10.86MInstitution
Deepa Prasad3.25%1,841,079$8.67MInsider

1 of 3

DSGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DSGN44.49%55.51%Net SellingNet Selling
QURE65.16%13.79%Net SellingNet Selling
PSTX54.52%40.45%Net Selling
PRLD51.84%48.16%Net SellingNet Selling
ADCT53.62%43.21%Net BuyingNet Buying
View Top Biotech Stocks

Design Therapeutics Stock Ownership FAQ

Who owns Design Therapeutics?

Design Therapeutics (NASDAQ: DSGN) is owned by 56.69% institutional shareholders, 70.72% Design Therapeutics insiders, and 0.00% retail investors. Simeon George is the largest individual Design Therapeutics shareholder, owning 12.15M shares representing 21.46% of the company. Simeon George's Design Therapeutics shares are currently valued at $56.75M.

If you're new to stock investing, here's how to buy Design Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.